Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Verve Therapeutics, Inc. | Chief Executive Officer, Director | Restricted Stock Units | 132K | $1.32M | $10.00 | Feb 14, 2024 | Direct |
Verve Therapeutics, Inc. | Chief Executive Officer, Director | Common Stock | 351K | $1.01M | $2.87 | Jun 28, 2024 | Direct |
Verve Therapeutics, Inc. | Chief Executive Officer, Director | Common Stock | 241K | $692K | $2.87 | Jun 28, 2024 | Kathiresan Family 2021 Irrevocable Trust |
Verve Therapeutics, Inc. | Chief Executive Officer, Director | Common Stock | 81K | $232K | $2.87 | Jun 28, 2024 | Sekar Kathiresan 2021 Irrevocable Trust |
Verve Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 215K | Jun 28, 2024 | Direct | ||
Verve Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 200K | Jun 28, 2024 | Sekar Kathiresan 2023 Annuity Trust | ||
Verve Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 160K | Jun 28, 2024 | Sekar Kathiresan 2022 Annuity Trust | ||
Relay Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 102K | Jun 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VERV | Verve Therapeutics, Inc. | Jun 28, 2024 | 2 | $86.1K | 4 | Jul 2, 2024 | Chief Executive Officer, Director |
RLAY | Relay Therapeutics, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Director |
VERV | Verve Therapeutics, Inc. | Feb 14, 2024 | 2 | $0 | 4 | Feb 16, 2024 | Chief Executive Officer, Director |
RLAY | Relay Therapeutics, Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 1, 2023 | Director |
VERV | Verve Therapeutics, Inc. | Feb 14, 2023 | 1 | $0 | 4 | Feb 16, 2023 | Chief Executive Officer, Director |
VERV | Verve Therapeutics, Inc. | Oct 3, 2022 | 5 | -$1.61M | 4 | Oct 5, 2022 | Chief Executive Officer, Director |
VERV | Verve Therapeutics, Inc. | Aug 10, 2022 | 3 | -$1.43M | 4 | Aug 11, 2022 | Chief Executive Officer, Director |
RLAY | Relay Therapeutics, Inc. | Jul 25, 2022 | 1 | $0 | 4 | Jul 27, 2022 | Director |
RLAY | Relay Therapeutics, Inc. | Jul 25, 2022 | 0 | $0 | 3 | Jul 27, 2022 | Director |
VERV | Verve Therapeutics, Inc. | Jul 19, 2022 | 3 | -$1.43M | 4 | Jul 21, 2022 | Chief Executive Officer, Director |
VERV | Verve Therapeutics, Inc. | Jul 7, 2022 | 6 | $0 | 4 | Jul 15, 2022 | Chief Executive Officer, Director |
VERV | Verve Therapeutics, Inc. | Mar 18, 2022 | 2 | $200K | 4 | Mar 22, 2022 | Chief Executive Officer, Director |
VERV | Verve Therapeutics, Inc. | Feb 11, 2022 | 1 | $0 | 4 | Feb 15, 2022 | Chief Executive Officer, Director |
VERV | Verve Therapeutics, Inc. | Jan 4, 2022 | 3 | -$72K | 4 | Jan 6, 2022 | Chief Executive Officer, Director |
VERV | Verve Therapeutics, Inc. | Dec 27, 2021 | 8 | -$1.89M | 4 | Dec 29, 2021 | Chief Executive Officer, Director |
VERV | Verve Therapeutics, Inc. | Dec 22, 2021 | 9 | -$4.32M | 4 | Dec 27, 2021 | Chief Executive Officer, Director |
VERV | Verve Therapeutics, Inc. | Jun 17, 2021 | 2 | $47.5K | 4 | Jun 21, 2021 | Chief Executive Officer, Director |
VERV | Verve Therapeutics, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | Chief Executive Officer, Director, 10%+ Owner |